Background: The implementation of acuity circles (AC) in 2020 and the COVID‐19 pandemic increased the use of local surgeons to recover livers for transplant; however, the impact on liver transplant (LT) outcomes is unknown.Methods: Deceased donor adult LT recipients from the UNOS database were identified. Recipients were grouped by donor surgeon: local versus primary recovery. Patient and graft survival as well as trends in local recovery in the 2 years pre‐AC and post‐AC were assessed.Results: The utilization of local recovery in LT increased from 22.3% to 37.9% post‐AC (p < 0.01). LTs with local recovery had longer cold ischemia times (6.5 h [5.4–7.8] vs. 5.3 h [4.4–6.5], p < 0.01) and traveled further (210 miles [89–373] vs. 73 miles [11–196], p < 0.01) than those using primary recovery. Multivariate analyses revealed no differences in patient or graft survival between local and primary recovery, and between OPO and local surgeon. There was no difference in survival when comparing simultaneous liver–kidney, donation after circulatory death, MELD ≥ 30, or redo‐LT by recovery team. Recovery and utilization rates were also noted to be higher post‐AC (51.4% vs. 48.6% pre‐AC, p < 0.01) as well as when OPO surgeons recovered the allografts (72.5% vs. 66.0%, p < 0.01).Conclusion: Nearly 40% of LTs are performed using local recovery, and utilization rates and trends continue to change with changing organ‐sharing paradigms such as AC. This practice appears safe with outcomes similar to recovery by the primary team in appropriately selected recipients and may lead to increased access and the ability to transplant more livers.
20 October 2023 in The American Journal of Surgery
Purpose: Surgical fellowship interviews shifted to a virtual platform in 2020 due to the COVID-19 pandemic. While virtual interviews provide convenience, they also pose difficulties for programs and raise potential barriers for applicants. This study compares in-person to virtual interviews and characterizes the impact on programs and applicants. Methods: In-person (2007–2019) and virtual (2020–2022) fellowship application data were extracted from publicly available NRMP Specialties Matching Service data. Fellowship programs included surgical critical care, surgical oncology, colorectal, pediatric, thoracic, and vascular surgery. Competitiveness was assessed using a validated normalized competitiveness index (NCI). Results: Since virtual interviews, rankings per applicant, a surrogate for program interview workload, increased for all fellowships except pediatric surgery. The most competitive subspecialties now include colorectal, pediatric, and thoracic surgery. For non-US MDs in these subspecialties, applicants per position decreased (pediatric), match rate decreased (thoracic), and NCI increased (thoracic) under virtual interviewing. However, for the least competitive subspecialties, non-US MDs had increased rankings per applicant (critical care and vascular), increased match rate (critical care and surgical oncology), and decreased NCI (surgical oncology) with virtual interviewing. Conclusions: Since the virtual platform was implemented, applicants have interviewed at and ranked more programs, subsequently increasing program workload. While this is positive for many applicants, a differential pattern of securing a fellowship emerged for non-US MD applicants. This finding is important for fellowship program directors to consider and ensure non-US MD applicants are not marginalized with the virtual platform. Level of Evidence: III
The utilization of COVID-19-positive donors has expanded the donor pool for transplantation since the initiation of COVID allograft utilization protocols. However, the biopsy-proven PCR transmission rate of COVID-19 from these allografts has not been well documented. In August 2021, an institutional COVID-19-positive allograft protocol was implemented for liver and kidney transplants. Post-reperfusion liver biopsies were obtained intra-operatively to evaluate for COVID-19 RNA, and post-operative day 7 nasopharyngeal reverse transcriptase polymerase chain reaction (RT-PCR) swabs were collected. The primary endpoints evaluated included COVID-19 RNA on biopsy and COVID-19 detected via nasopharyngeal RT-PCR swab on post-operative day 7. A total of 20 vaccinated recipients underwent transplantation (17 liver only, 3 simultaneous liver and kidney) with whole liver allografts from 20 COVID-19-positive deceased donors between August 2021 and April 2022. 95% (19/20) of donors were asymptomatic at the time of donation. On post-reperfusion liver allograft biopsies, COVID-19 RNA was found in 10% (2/20) of the samples. All the recipients were COVID-19-negative on post-operative day 7 nasopharyngeal RT-PCR, showing a 0% transmission rate of COVID-19 from the positive allografts. The use of COVID-19 allografts appears to be a safe practice, with no PCR-detectable transmission of COVID-19 despite 10% of the liver allografts having COVID-19 RNA present on post-reperfusion biopsy.
Background: Historically, treatment approaches for metaplastic breast cancer (MpBC) have mirrored that of triple-negative ductal breast cancer (TN-IDC), yet MpBC has persistently worse survival. This study describes rates and response to neoadjuvant systemic therapy (NAC) for MpBC and evaluates survival between triple-negative MpBC (TN-MpBC), biomarker-positive MpBC (nTN-MpBC), and TN-IDC by treatment approach. Methods: The National Cancer Database was queried for females diagnosed with clinically non-metastatic MpBC or TN-IDC from 2011 to 2021. One-to-one propensity score matching between TN-MpBC and TN-IDC patients was performed. Results: Of 5575 MpBC patients, surgery and chemotherapy rates were high. For patients who received systemic therapy and surgery, an adjuvant approach was favored; however, NAC for TN-MpBC increased from 18.3 to 31.5% by 2021. Higher rates of NAC non-response and lower overall survival were found among MpBC cohorts compared with TN-IDC. For MpBC, an adjuvant approach had significantly better survival than other systemic therapy sequences. When evaluated by pathologic response to NAC, a partial or non-response had worse survival compared with complete response or not undergoing NAC. On Cox proportional hazard regression of matched patients, NAC had an adjusted hazard ratio of 2.56 (1.36–4.79) compared with not undergoing NAC. Conclusion: MpBC is predominantly treated with surgery and systemic therapy, with increasing rates of NAC for TN-MpBC. However, patients with MpBC have inferior survival to TN-IDC, and NAC for MpBC is associated with worse survival compared with other systemic therapy sequences, unless a complete pathologic response is achieved. These findings reinforce the need for systemic treatment sequence optimization for MpBC.
Background: The Choosing Wisely® (CW) campaign recommended de-implementation of surgical management of axillary nodes in specified patients. This study aimed to assess trends in the application of CW guidelines for lymph node (LN) surgery in males with breast cancer. Methods: The National Cancer Database was queried for males diagnosed with breast cancer from 2017 to 2020. Patients were categorized into two cohorts based on CW criteria. Cohort 1 included all T1-2, clinically node-negative patients who underwent breast-conserving therapy and with ≤ 2 positive nodes, and Cohort 2 included all T1-2, node-negative, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative patients aged ≥ 70 years. In Cohort 1, patients who underwent sentinel LN biopsy (SLNB) alone were compared with axillary LN dissection (ALND) or no LN surgery, while in Cohort 2, patients who underwent LN surgery were compared with those with no LN surgery. Results: Of 617 patients who met the criteria for Cohort 1, 73.1% underwent SLNB alone compared with ALND (11.8%) or no LN surgery (15.1%). Those who received SLNB alone were younger (65 vs. 68 vs. 73 years; p < 0.001). The annual proportion of males who underwent SLNB alone remained stable from 2017 to 2020. Overall, 1565 patients met the criteria for Cohort 2, and 84.9% received LN surgery. LN surgery was omitted in older patients (81 vs. 77; p < 0.001). The proportion of elderly males with early-stage breast cancer who underwent LN surgery increased from 2017 to 2020. Conclusion: This study demonstrates that CW recommendations are not being routinely applied to males. These findings reinforce the need for additional studies and subsequent recommendations for optimal application of axillary surgery de-implementation for males diagnosed with breast cancer.